%0 Journal Article
%T Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials
%A Eric Lim
%A Haiquan Chen
%A Hua Zhang
%A Josephine Hai
%A Justin Stebbing
%A Mark A. Socinski
%A Qingyuan Huang
%J Archive of "Oncoimmunology".
%D 2018
%R 10.1080/2162402X.2017.1396403
%K anti-PD-1
%K atezolizumab
%K immunotherapy
%K nivolumab
%K non-small cell lung cancer
%K pembrolizumab
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279417/